Literature DB >> 26212817

Biology and Treatment of Paget's Disease of Bone.

Mahéva Vallet1, Stuart H Ralston1.   

Abstract

Paget's disease of bone (PDB) is a common skeletal disorder characterized by increased and disorganized bone remodeling affecting one or more skeletal sites. Although some patients are asymptomatic others develop complications such as bone pain, deformity, nerve compression syndromes, and fragility fractures. Genetic factors play an important role in the pathogenesis of PDB and there is strong evidence that susceptibility is determined by variants within or close to genes that regulate osteoclast function. Environmental factors also play a key role but the nature of the environmental triggers is less clear. Bisphosphonates are a highly effective treatment for the elevations in bone turnover that are characteristic of PDB but it is unclear at present if they alter the natural history of the disease. Here, we review the epidemiology, clinical, cellular, and molecular abnormalities in PDB as well as environmental and genetic triggers, and current available treatment options.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  BISPHOSPHONATES; BONE DISEASE; PAGET'S DISEASE

Mesh:

Year:  2015        PMID: 26212817     DOI: 10.1002/jcb.25291

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  19 in total

Review 1.  Paget's Disease of Bone.

Authors:  Luigi Gennari; Domenico Rendina; Alberto Falchetti; Daniela Merlotti
Journal:  Calcif Tissue Int       Date:  2019-01-23       Impact factor: 4.333

2.  NFAM1 signaling enhances osteoclast formation and bone resorption activity in Paget's disease of bone.

Authors:  Yuvaraj Sambandam; Kumaran Sundaram; Takamitsu Saigusa; Sundaravadivel Balasubramanian; Sakamuri V Reddy
Journal:  Bone       Date:  2017-05-12       Impact factor: 4.398

3.  p62/sequestosome 1 deficiency accelerates osteoclastogenesis in vitro and leads to Paget's disease-like bone phenotypes in mice.

Authors:  Frank Zach; Franziska Polzer; Alexandra Mueller; André Gessner
Journal:  J Biol Chem       Date:  2018-03-19       Impact factor: 5.157

4.  215th ENMC International Workshop VCP-related multi-system proteinopathy (IBMPFD) 13-15 November 2015, Heemskerk, The Netherlands.

Authors:  Teresinha Evangelista; Conrad C Weihl; Virginia Kimonis; Hanns Lochmüller
Journal:  Neuromuscul Disord       Date:  2016-05-30       Impact factor: 4.296

Review 5.  Alkaline Phosphatase Replacement Therapy for Hypophosphatasia in Development and Practice.

Authors:  S A Bowden; B L Foster
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

6.  Deficiency of optineurin enhances osteoclast differentiation by attenuating the NRF2-mediated antioxidant response.

Authors:  Peng Xue; Xiangxiang Hu; Emily Chang; Lufei Wang; Minghui Chen; Tai-Hsien Wu; Dong-Joon Lee; Brian L Foster; Henry C Tseng; Ching-Chang Ko
Journal:  Exp Mol Med       Date:  2021-04-16       Impact factor: 8.718

Review 7.  Sphingosine 1-phosphate signaling in bone remodeling: multifaceted roles and therapeutic potential.

Authors:  Anastasia Meshcheryakova; Diana Mechtcheriakova; Peter Pietschmann
Journal:  Expert Opin Ther Targets       Date:  2017-06-07       Impact factor: 6.902

8.  Antibody Response to Paramyxoviruses in Paget's Disease of Bone.

Authors:  Micaela Rios Visconti; Ricardo Usategui-Martín; Stuart H Ralston
Journal:  Calcif Tissue Int       Date:  2017-03-31       Impact factor: 4.333

9.  PSMA-PET/CT-Positive Paget Disease in a Patient with Newly Diagnosed Prostate Cancer: Imaging and Bone Biopsy Findings.

Authors:  Michael Froehner; Marieta Toma; Klaus Zöphel; Vladimir Novotny; Michael Laniado; Manfred P Wirth
Journal:  Case Rep Urol       Date:  2017-03-15

Review 10.  Epidemiology and pathology of Paget's disease of bone - a review.

Authors:  Elena Nebot Valenzuela; Peter Pietschmann
Journal:  Wien Med Wochenschr       Date:  2016-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.